Horizon Technology Finance Corp HRZN

Nasdaq

We are a specialty finance company that lends to and invests in development-stage companies in the technology, life science, healthcare information and services and sustainability industries, which we refer to as our "Target Industries." Our investment objective is to maximize our investment portfolio's total return by generating current income from the debt investments we make and capital appreciation from the warrants we receive when making such debt investments. We are focused on making secured debt investments, which we refer to as "Venture Loans," to venture capital and private equity backed companies and publicly traded companies in our Target Industries, which we refer to as "Venture Lending." Our debt investments are typically secured by first liens or first liens behind a secured revolving line of credit, or collectively, "Senior Term Loans." Some of our debt investments may also be subordinated to term debt provided by third parties. Venture Lending is typically characterized by (1) the making of a secured debt investment after a venture capital or equity investment in the portfolio company has been made, which investment provides a source of cash to fund the portfolio company's debt service obligations under the Venture Loan, (2) the senior priority of the Venture Loan which requires repayment of the Venture Loan prior to the equity investors realizing a return on their capital, (3) the amortization of the Venture Loan and (4) the lender's receipt of warrants or other success fees with the making of the Venture Loan.

Last close 4.84 2026-09-04
Market cap $324.4M 2026-06-30 share count
52-week range 3.80 - 6.97

Valuation FY2025 figures against the last close

P/S
P/E
P/FCF5.7x
EV/EBITDA
Dividend yield16.4%
Diluted EPS-0.06

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020
SG&A $1.9M$1.9M$1.8M$1.5M$1.5M$1.2M
Total operating expenses $50.5M$50.7M$50.5M$42.3M$31.4M$25.1M
Interest expense $32.8M$32.3M$29.0M$19.2M$12.0M$9.7M
Net income -$2.7M-$5.6M-$17.2M$21.2M$27.8M$6.4M
EPS, basic -0.06-0.16-0.560.861.411.18
EPS, diluted -0.06-0.16-0.560.86
Shares, diluted (wtd. avg.) $42.3M$36.1M$31.0M$24.7M$20.0M$17.5M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents $142.7M$100.9M$75.7M$30.5M$47.3M$47.8M
Total assets $811.1M$821.8M$802.4M$766.8M$514.0M
Long-term debt $473.0M$467.9M$462.2M$434.1M$257.6M
Total liabilities $492.6M$485.6M$478.4M$448.4M$268.6M
Retained earnings -$240.9M-$182.1M-$127.0M-$67.5M-$56.0M
Total equity $318.5M$336.2M$324.0M$318.4M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020
Operating cash flow $56.6M$3.9M-$5.3M-$246.3M-$76.0M-$25.3M
Financing cash flow -$14.8M$21.2M$50.5M$229.5M$75.5M$55.7M
Dividends paid $53.1M$46.4M$40.5M$29.8M$24.6M$21.3M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001437749-26-013973.